The Discounted Cash Flow (DCF) valuation of Shanghai Henlius Biotech Inc (2696.HK) is (14.24) HKD. With the latest stock price at 64.60 HKD, the upside of Shanghai Henlius Biotech Inc based on DCF is -122.0%.
Based on the latest price of 64.60 HKD and our DCF valuation, Shanghai Henlius Biotech Inc (2696.HK) is a sell. selling 2696.HK stocks now will result in a potential gain of 122.0%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 10.4% | 8.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (21.34) - (11.94) | (14.24) |
| Upside | -133.0% - -118.5% | -122.0% |